 | | Enfuvirtide (Fuzeon) |  | | Published
March 17, 2003; Updated
September 21, 2007 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-04-01 | | | Selected Reference | | 9. | Greenberg ML, Melby T, Sista P, DeMasi R, Cammack N, Salgo M, Whitcomb J, Petropoulos C, Matthews TJ. Baseline and on-treatment susceptibility to Enfuvirtide seen in TORO 1 and TORO 2 to 24 weeks. 10th Conference on Retroviruses and Opportunistic Infections. February 10-14, 2003, Boston. Abstract 141. | |
|
|
|
